Pure Global
NCT05624177

Colonisation Efficacy of a Probiotic Chewing Gum.

BLIS Technologies Limited·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Microbial Colonization
Drug/Device/Intervention
Streptococcus salivarius M18 probiotic 1 billion colony forming units chewing gum (chew 5 minutes)
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
BLIS Technologies Limited
Location
Dunedin, New Zealand
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2022
End date
Mar 01, 2023
Enrollment
20 participants
Primary outcome

Change in Microbial colonization from baseline (Day 0) to 1 hour.,Change in Microbial colonization from baseline (Day 0) to 8 hours.,Change in Microbial colonization from baseline (Day 0) to 8 hours post last dose.,Change in Microbial colonization from baseline (Day 0) to 48 hours post last dose.

Summary

To evaluate the colonization efficacy (the ability of a probiotic bacteria to remain in the
 mouth) delivered in a chewing gum format. The chewing gum contains Streptococcus salivarius
 probiotic and the study is to be done in health adults.

ICD-10 classifications
Bacterial infection of unspecified siteOther bacterial infections of unspecified siteBacterial, viral and other infectious agentsCholeraOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05624177
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05624177 through Pure Global AI's free database. This phase not specified trial is sponsored by BLIS Technologies Limited and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.